All In MedTech

Device Trial Radar · NCT02228889

RCT of Two Noncrosslinked Porcine Acellular Dermal Matrices in Ab Wall Reconstruction

Prospective Trial Comparing the Performance Profiles of Two Non-Cross-Linked Porcine Dermal Matrices in Abdominal Wall Reconstruction

Last checked: Nov 19, 2026Latest source record: Jun 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

46

Actual

Start

Jan 2015

Primary completion

Mar 27, 2025

Study completion Mar 27, 2025

Sponsor

Lead sponsor
Jeffrey JanisAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 29, 2014

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 99 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to compare the clinical outcomes of two commonly used, FDA-approved biologic meshes in hernia repair and abdominal wall reconstruction (Strattice and XenMatrix). The two meshes are derived from pig skin from which cells have been removed and which have been sterilized. The two meshes are made by two different companies using different processes.

Conditions

  • Hernia, Ventral
  • Intestinal Fistula
  • Fibromatosis, Abdominal

Interventions

  • Abdominal wall reconstruction with StratticeProcedure

    Abdominal wall reconstruction using Strattice

  • Assess pain intensity at last office visit preoperativelyOther

    Assess patient pain intensity preoperatively using the PROMIS Pain Intensity survey (average of 1-3 weeks preoperatively)

  • Assess pain interference at last office visit preoperativelyOther

    Assess pain interference preoperatively using the PROMIS pain interference survey (average of 1-3 weeks preoperatively)

  • Assess physical functioning at last office visit preoperativelyOther

    Assess physical functioning preoperatively using the PROMIS physical functioning survey (average of 1-3 weeks preoperatively)

  • Assess patient quality of life at last office visit preoperativelyOther

    Assess patient quality of life preoperatively, using the HerQLes survey (average of 1-3 weeks preoperatively)

  • Assess patient pain intensity postoperativelyOther

    Assess patient pain intensity at 1 year postoperatively using the PROMIS Pain Intensity survey

  • Assess pain interference postoperativelyOther

    Assess pain interference at 1 year postoperatively using the PROMIS Pain Interference survey

  • Assess physical functioning postoperativelyOther

    Assess physical functioning at 1 year postoperatively using the PROMIS Physical Functioning Survey

  • Assess quality of life postoperativelyOther

    Assess quality of life at 1 year postoperatively using the HerQLes survey

  • Assess hernia recurrence at 30 days postoperativelyOther

    Assess hernia recurrence at 30 days

  • Assess bulge at 30 days postoperativelyOther

    Assess bulge at 30 days

  • Assess Surgical Site Occurrences at 30 days postoperativelyOther

    Assess Surgical Site Occurrences at 30 days

  • Assess hernia recurrence at 1 year postoperativelyOther

    Assess hernia recurrence at 1 year postoperatively

  • Assess bulge at 1 year postoperativelyOther

    Assess bulge at 1 year postoperatively

  • Assess Surgical Site Occurrences at 1 year postoperativelyOther

    Assess Surgical Site Occurrences at 1 year postoperatively

  • Assess overall complications at 30 days postoperativelyOther

  • Assess overall complications at 1 year postoperativelyOther

  • Abdominal wall reconstruction with XenMatrixProcedure

    Abdominal wall reconstruction with XenMatrix

  • StratticeDevice

    Strattice mesh

  • XenMatrixDevice

    Xenmatrix mesh

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of Surgical Site Occurrences (SSOs) at 6 WeekTime frame: 6 week postoperatively

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The Ohio State University Wexner Medical Center

    Columbus, Ohio

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.